Skip to main content
Premium Trial:

Request an Annual Quote

SEC Gives Green Light for Pharmacopeia Spin-off

NEW YORK, April 20 (GenomeWeb News) - The SEC has declared the registration statement on Form 10 of Pharmacopeia Drug Discovery effective, thus clearing the way for PDD's spin-off to Pharmacopeia stockholders, Pharmacopeia said yesterday.

 

PDD common stock was expected to begin trading on a "when issued" basis on the Nasdaq National Market today under the ticker symbol "PCOPV".

 

Pharmacopeia announced its intention to spin off its drug discovery unit in December.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.